论文部分内容阅读
2型糖尿病患者心血管疾病的发生率和死亡率较非糖尿病人群显著增高的重要原因之一就是血脂异常。本研究旨在探讨辛伐他汀在治疗2型糖尿病脂代谢紊乱方面的作用。
One of the major causes of cardiovascular disease and mortality in patients with type 2 diabetes is significantly higher than non-diabetic patients is dyslipidemia. This study aimed to investigate the role of simvastatin in the treatment of lipid metabolism disorder in type 2 diabetic patients.